Drug
ONO2506 clinical trials
Also written ONO-2506PO and ONO-2506.
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Ono Pharmaceutical Co. Ltd (3) · Ono Pharma USA Inc (2) · Ono Pharmaceutical Co., Ltd. (1) · Merck Sharp & Dohme LLC (1)
Studies
Open first, then newest update. How each study uses ONO2506 is read from its arms, and is right about nine times in ten.
Testing it · 7
- The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018)TerminatedPhase 2Merck Sharp & Dohme LLCNCT00401310Written as Comparator: MK0724
- Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in JapanCompletedPhase 2Ono Pharmaceutical Co., Ltd.NCT00212693Written as ONO-2506PO
- A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic StrokeTerminatedPhase 2/3Ono Pharma USA IncNCT00046761Written as ONO-2506
- Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedPhase 2Ono Pharmaceutical Co. LtdNCT00403104Written as ONO-2506PO
- A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)CompletedPhase 2Ono Pharmaceutical Co. LtdNCT00694941Written as ONO-2506PO
- Effects of ONO-2506PO in Patients With Alzheimer's DiseaseCompletedPhase 2Ono Pharma USA IncNCT00083421Written as ONO-2506PO
- Study of ONO-2506 in Patients With Acute Ischemic StrokeCompletedPhase 2/3Ono Pharmaceutical Co. LtdNCT00229177Written as ONO-2506